Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical darolutamide tissue-acquisition study in early breast cancer
2016-004151-79Phase 2Completed
- Sponsor
- Translational Research In Oncology
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of darolutamide in breast cancer, sponsored by Translational Research In Oncology. Started Jan 2017; status: completed.
02
Drugs
darolutamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-004151-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004151-79.